CytoMed Therapeutics
GDTC
#9506
Rank
A$40.49 M
Marketcap
$3.51
Share price
-9.41%
Change (1 day)
-44.75%
Change (1 year)

CytoMed Therapeutics (GDTC) - Cash on Hand

Cash on Hand as of December 2023 : A$10.34 Million

According to CytoMed Therapeutics's latest financial reports the company has A$10.34 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CytoMed Therapeutics - Cash on Hand chart (from 2021 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$1.73 M-32.46%
2021-12-31A$2.56 M194.6%
2020-12-31A$0.87 M